HIPRA HUMAN HEALTH S.L.U.
Contact information
- Cell cultures
- Drug development
- Drug discovery
- Vaccines
- Infectious diseases
- Immunology
- Animal health / Veterinary
- CRO / CMO / SMO
HIPRA is a biotechnological pharmaceutical company focused on prevention for animal and human health, with a broad range of highly innovative vaccines and an advanced diagnostic service. With its claim "Building immunity for a healthier world", HIPRA affirms its commitment to contributing with solutions that improve global health. It has its own subsidiaries in 40 countries, 3 R&D centers and 6 production centers locates in Spain and Brazil.
Hipra, which dedicates more than 10% of its annual turnover to R&D, carries out and controls all stages of development of its services and biological products in its facilities, which are equipped with the latest technological advances. HIPRA is the company that has launched the most biotech vaccines in the last 10 years, with a total of 21 vaccines.
Development and manufacturing of biological products for animal health and human health.
Internationalization (participation in national and international events).
Access to financing tools.